PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients

BACKGROUND: Agents targeting programmed death-1 receptor (PD-1) and its ligand (PD-L1) are showing promising results in non-small-cell lung cancer (NSCLC). It is unknown whether PD-1/PD-L1 are differently expressed in oncogene-addicted NSCLC. METHODS: We analysed a cohort of 125 NSCLC patients, incl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: D'Incecco, A, Andreozzi, M, Ludovini, V, Rossi, E, Capodanno, A, Landi, L, Tibaldi, C, Minuti, G, Salvini, J, Coppi, E, Chella, A, Fontanini, G, Filice, M E, Tornillo, L, Incensati, R M, Sani, S, Crinò, L, Terracciano, L, Cappuzzo, F
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453606/
https://ncbi.nlm.nih.gov/pubmed/25349974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.555
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados